Temel, M. Et Al. 2004. A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines. Annual European Congress of Rheumatology (EULAR 2004) , (Berlin, Germany), 407.

Temel, M., Atagunduz, P., & Direskeneli, H., (2004). A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines . Annual European Congress of Rheumatology (EULAR 2004) (pp.407). Berlin, Germany

Temel, M, P Atagunduz, And RAFİ HANER DİRESKENELİ. "A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines," Annual European Congress of Rheumatology (EULAR 2004), Berlin, Germany, 2004

Temel, M Et Al. "A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines." Annual European Congress of Rheumatology (EULAR 2004) , Berlin, Germany, pp.407, 2004

Temel, M. Atagunduz, P. And Direskeneli, H. (2004) . "A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines." Annual European Congress of Rheumatology (EULAR 2004) , Berlin, Germany, p.407.

@conferencepaper{conferencepaper, author={M Temel Et Al. }, title={A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines}, congress name={Annual European Congress of Rheumatology (EULAR 2004)}, city={Berlin}, country={Germany}, year={2004}, pages={407} }